Irinotecan Hydrochloride
Product Images NDC 72485-213

4 FDA label images from Armas Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 72485-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (7248521315)

Image Description (7248521315)
Packaging label for Irinotecan Hydrochloride Injection, USP 300 mg/15 mL (20 mg/mL) by Armas Pharmaceuticals Inc. The box indicates one 15 mL single-dose vial for intravenous use only, with a caution noting it as a cytotoxic agent. The label includes storage instructions and manufacturer details from Shilpa Medicare Limited, India.*
FDA Label Image

Image Description (Fig3)

Image Description (Fig3)
A survival curve comparing second-line Irinotecan versus Best Supportive Care (BSC) in Study 7. The chart plots probability of survival over 21 months, showing two lines representing Irinotecan and BSC groups. The graph includes median follow-up and median survival times for each group, along with a p-value from a log-rank test.*
FDA Label Image

Image Description (Fig4)

Image Description (Fig4)
A survival curve graph comparing second-line Irinotecan versus Infusion 5-FU (5-fluorouracil) from Study 8. The y-axis shows probability from 0 to 1, and the x-axis shows months from 0 to 21. Two curves represent patient survival probabilities over time for Irinotecan and 5-FU. Median follow-up and median survival in months are included with Irinotecan at 10.8 months and 15 months for 5-FU. A p-value (0.0035) from a log-rank test is also noted.*
FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure of irinotecan hydrochloride trihydrate illustrating its molecular arrangement including rings, functional groups, and hydration state.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.